Sorry, we’re not accepting applications for this job right now. But don’t go yet! Explore our site
to find more opportunities to join us in transforming the future of health care.
BlueSphere Bio (formally known as TCXpress) is an immunotherapy startup that is the first translational science spinout from UPMC Enterprises. BlueSphere Bio raised a Series A round of $10M in the 4Q of 2018.
We are currently recruiting for a highly motivated and creative T cell engineering scientist to join our discovery group for the development of personalized adoptive T cell therapies deriving from our TCXpress platform technology. The primary focus of the candidate will be on synthetic biology for the generation of new T cell receptor constructs and gene editing in primary T cells. The candidate will lead and conduct experiments and closely interact with both early discovery and clinical development groups. The role requires extensive knowledge of T-cell Immunobiology and expertise in Molecular Biology techniques. Candidate could also serve as a project leader for the preclinical development of therapeutic targets based on qualifications and experience.Responsibilities:
- Contribute with the development and writing of new intellectual property.
- Design and engineer novel T cell receptor constructs that will serve as candidates for further clinical development.
- Establish viral and non-viral technologies for the delivery of nucleic acids to human primary T cells.
- In collaboration with early discovery and development characterize constructs with in vitro and ex vivo biochemical and functional assays using T cell lines and primary T cells.
- Interact with CROs and CMOs for validation and manufacturing of candidate constructs.
- Lead the development of engineered human primary T cells using CRISPR/Cas9 gene editing technologies to suppress endogenous TCR expression and to increase effector functions of receptors selected by our TCXpress platform.
- Lead, train and mentor junior staff.
- Present regularly to management and team meetings, contributing with scientific insights and helping with the overall strategy.
- Provide expertise on T cell immunology with emphasis into T cell receptor signaling and structure and function relationship.
- Responsible for Gene Editing and Synthetic Biology.
- PhD. in Immunology, Oncology, Bioengineering with strong background in Molecular Biology with at least 2-5 years of Post-Doctoral experience in either academic or industrial setting.
- Hands on experience with gene editing using engineered nucleases such as ZFNs, TALENs, or CRISPR/Cas9 is highly desired.
- Significant knowledge of T cell biology and signal transduction research including areas such as allo-recognition, T cell suppression and exhaustion in the tumor microenviroment is preferred.
- Proven record of design, synthesis and validation of CAR-T or TCR-T constructs as evidenced by publications, presentations at scientific meetings or IP filings.
- Technical expertise in using latest molecular biology techniques in cloning and experienced in using retrovirus/lentivirus transduction in human primary T cells.
- Previous hands-on experience with immunological assays including cell based assays, ELISAs, ELISPOTs, cytokine secretion, cytotoxicity, proliferation and exhaustion assays, fluorescent microscopy and immunohistochemical tissue staining.
- Significant experience with isolation of immune cell subpopulations from human peripheral blood lymphocytes and/or tumors and their characterization using multi-parameter flow cytometry and data analysis.
- Prior experience with expression analysis using qPCR and/or cell-based assays is highly preferred.
- Previous laboratory supervision or project leadership experience is highly desired.
Licensure, Certifications, and Clearances:
UPMC is an equal opportunity employer. Minority/Females/Veterans/Individuals with Disabilities